← All Alzamend Neuro, INC filings

Alzamend Neuro, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
ALZN
Alzamend Neuro, INC
S-1/A: Alzamend Neuro Files Amendment to Registration Statement for Resale of 75.8 Million Shares
Alzamend Neuro is filing an amendment to its registration statement to allow a selling stockholder to resell up to 75,775,110 shares of common stock.
NASDAQ
ALZN
Alzamend Neuro, INC
S-1/A: Alzamend Neuro Seeks to Resell 125 Million Shares of Common Stock Through S-1/A Filing
Alzamend Neuro files an S-1/A registration statement to resell up to 125 million shares of common stock, primarily for the benefit of Orchid Finance LLC.
NASDAQ
ALZN
Alzamend Neuro, INC
S-1/A: Alzamend Neuro Seeks to Raise Capital Through Resale of Common Stock by Orchid Finance LLC
Alzamend Neuro is registering for resale up to 125,000,000 shares of its common stock by Orchid Finance LLC, obtained through conversion of preferred shares and exercise of warrants.
NASDAQ
ALZN
Alzamend Neuro, INC
S-1: Alzamend Neuro Files for Resale of 125 Million Shares Amid Nasdaq Listing Concerns
Alzamend Neuro is registering for resale up to 125 million shares of common stock by Orchid Finance LLC, while also addressing ongoing Nasdaq listing compliance issues.